IVFmicro is a University of Leeds spin-out focused on improving in-vitro fertilisation (IVF) outcomes by using a proprietary microfluidic device that cultures embryos in ultra-small volumes of nutrient-rich fluid. The technology is designed to reduce repeated handling and subjective embryo selection, two factors that can hamper IVF success rates, and the company reports a 10–15 % improvement in both embryo quality and quantity. By increasing viable embryos per cycle, IVFmicro ultimately hopes to lower overall treatment costs and raise pregnancy success rates for patients. The mission addresses a significant need, with roughly one in six couples worldwide facing fertility issues and UK IVF cycles costing about £5,000 on average. Current IVF success rates for women under 35 stand at only 25–30 %, highlighting the potential impact of the solution. With fresh capital in place, IVFmicro will move into verification and validation work before commencing trials with human embryos in partner fertility clinics. The company’s scientific leadership is headed by co-founder and Scientific Director Helen Picton, who is leveraging extensive reproductive-biology research to bring the product to market.

Total raised

$5M

Funding rounds

1

Latest round

Seed

Latest activity

Dec 2025